These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 525344)

  • 1. Lead intoxication as an etiologic factor in hyperkinetic behavior in children: a negative report.
    Hole K; Dahle H; Kløve H
    Acta Paediatr Scand; 1979 Sep; 68(5):759-60. PubMed ID: 525344
    [No Abstract]   [Full Text] [Related]  

  • 2. [Concentration of lead in the blood of children with hyperkinesis].
    Vega-Franco L; Hernández Romo A; Meza Camiacho C; Calderón F
    Bol Med Hosp Infant Mex; 1976; 33(5):1143-9. PubMed ID: 973862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of lead in hyperactivity.
    David OJ; Hoffman SP; Sverd J
    Psychopharmacol Bull; 1976 Apr; 12(2):11-3. PubMed ID: 1257385
    [No Abstract]   [Full Text] [Related]  

  • 4. Lead and hyperactivity: lead levels among hyperactive children.
    David OJ; Hoffman SP; Sverd J; Clark J
    J Abnorm Child Psychol; 1977 Dec; 5(4):405-16. PubMed ID: 604381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treadmill of lead.
    Chaiklin H
    Am J Orthopsychiatry; 1979 Oct; 49(4):571-573. PubMed ID: 495699
    [No Abstract]   [Full Text] [Related]  

  • 6. Lead and hyperactivity. Behavioral response to chelation: a pilot study.
    David OJ; Hoffman SP; Sverd J; Clark J; Voeller K
    Am J Psychiatry; 1976 Oct; 133(10):1155-8. PubMed ID: 823826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lead and hyperactivity.
    David O; Clark J; Voeller K
    Lancet; 1972 Oct; 2(7783):900-3. PubMed ID: 4116603
    [No Abstract]   [Full Text] [Related]  

  • 8. Chelation therapy in children as treatment of sequelae in severe lead toxicity.
    David OJ; Katz S; Arcoleo CG; Clark J
    Arch Environ Health; 1985; 40(2):109-13. PubMed ID: 4004343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure to find hyperactivity in preschool children with moderately elevated lead burden.
    Milar CR; Schroeder SR; Mushak P; Boone L
    J Pediatr Psychol; 1981 Mar; 6(1):85-95. PubMed ID: 7252717
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: A study of lead concentrations in blood of children (and some adults) of Southern Tasmania.
    Bloom H; Lewis IC; Noller BN
    Med J Aust; 1974 Nov; 2(22):823-4. PubMed ID: 4456158
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathobiological and behavioral effects of lead intoxication in the infant rhesus monkey.
    Allen JR; McWey PJ; Suomi SJ
    Environ Health Perspect; 1974 May; 7():239-46. PubMed ID: 4208658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between lower level lead concentrations and hyperactivity in children.
    David OJ
    Environ Health Perspect; 1974 May; 7():17-25. PubMed ID: 4831139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lead and human behaviour.
    Waldron HA
    J Ment Defic Res; 1978 Mar; 22(1):69-78. PubMed ID: 355634
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperactivity and brain catecholamines in lead-exposed developing rats.
    Sauerhoff MW; Michaelson IA
    Science; 1973 Dec; 182(4116):1022-4. PubMed ID: 4795926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lead-inducing hyperactivity. Chronic exposure during the neonatal period in the rat.
    Kostas J; McFarland DJ; Drew WG
    Pharmacology; 1976; 14(5):435-42. PubMed ID: 1036336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lead poisoning in children: neurologic implications of widespread subclinical intoxication.
    Needleman HL
    Semin Psychiatry; 1973 Feb; 5(1):47-54. PubMed ID: 4807814
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuropsychological effects of chronic asymptomatic increased lead absorption. A controlled study.
    Baloh R; Sturm R; Green B; Gleser G
    Arch Neurol; 1975 May; 32(5):326-30. PubMed ID: 1137507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early-life lead exposure recapitulates the selective loss of parvalbumin-positive GABAergic interneurons and subcortical dopamine system hyperactivity present in schizophrenia.
    Stansfield KH; Ruby KN; Soares BD; McGlothan JL; Liu X; Guilarte TR
    Transl Psychiatry; 2015 Mar; 5(3):e522. PubMed ID: 25756805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chelating agents in treatment of lead intoxication.
    Freeman R
    J Pediatr; 1969 Feb; 74(2):322-3. PubMed ID: 4973956
    [No Abstract]   [Full Text] [Related]  

  • 20. [Origins and forms of the hyperkinesis syndrome].
    Degen R
    Krankenpfl J; 1985 Dec; 23(12):29. PubMed ID: 3853644
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.